Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Birth Weight | 4 | 2022 | 90 | 1.490 |
Why?
|
Adiposity | 5 | 2022 | 154 | 1.450 |
Why?
|
Biological Specimen Banks | 2 | 2021 | 25 | 1.440 |
Why?
|
Insulin Resistance | 4 | 2024 | 184 | 1.180 |
Why?
|
Educational Status | 5 | 2022 | 313 | 1.100 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2018 | 162 | 1.100 |
Why?
|
DNA Methylation | 3 | 2021 | 325 | 1.080 |
Why?
|
Reproductive Techniques, Assisted | 4 | 2023 | 31 | 1.080 |
Why?
|
Pregnancy | 17 | 2023 | 1549 | 1.040 |
Why?
|
Life Style | 3 | 2022 | 308 | 1.030 |
Why?
|
Pregnancy Complications | 3 | 2022 | 126 | 1.020 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 219 | 0.990 |
Why?
|
Behavioral Symptoms | 1 | 2023 | 6 | 0.890 |
Why?
|
Child | 15 | 2024 | 3131 | 0.890 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 664 | 0.880 |
Why?
|
Socioeconomic Factors | 5 | 2022 | 1067 | 0.860 |
Why?
|
Perinatal Care | 1 | 2022 | 15 | 0.850 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 105 | 0.840 |
Why?
|
Play and Playthings | 1 | 2022 | 12 | 0.830 |
Why?
|
Singapore | 7 | 2022 | 14 | 0.820 |
Why?
|
Skinfold Thickness | 1 | 2021 | 7 | 0.810 |
Why?
|
Executive Function | 1 | 2022 | 49 | 0.810 |
Why?
|
Metabolomics | 1 | 2022 | 81 | 0.810 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 333 | 0.800 |
Why?
|
Humans | 39 | 2024 | 37093 | 0.800 |
Why?
|
Female | 28 | 2024 | 20969 | 0.790 |
Why?
|
Vitamin D | 2 | 2014 | 196 | 0.780 |
Why?
|
Cardiovascular System | 1 | 2021 | 33 | 0.780 |
Why?
|
Body Height | 1 | 2021 | 53 | 0.780 |
Why?
|
Prospective Studies | 11 | 2024 | 1378 | 0.750 |
Why?
|
Mothers | 1 | 2023 | 181 | 0.750 |
Why?
|
Metabolic Diseases | 2 | 2021 | 33 | 0.740 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 12 | 0.720 |
Why?
|
Body Weight | 1 | 2021 | 434 | 0.680 |
Why?
|
Risk Factors | 11 | 2024 | 3562 | 0.680 |
Why?
|
Motor Vehicles | 1 | 2019 | 11 | 0.670 |
Why?
|
Transportation | 1 | 2019 | 26 | 0.660 |
Why?
|
Coronary Disease | 1 | 2020 | 124 | 0.660 |
Why?
|
Automobile Driving | 1 | 2019 | 24 | 0.650 |
Why?
|
Weight Gain | 3 | 2022 | 136 | 0.650 |
Why?
|
Accidents, Traffic | 1 | 2019 | 42 | 0.650 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2018 | 6 | 0.650 |
Why?
|
Pyrethrins | 1 | 2018 | 6 | 0.650 |
Why?
|
DDT | 1 | 2018 | 15 | 0.640 |
Why?
|
Insecticides | 1 | 2018 | 51 | 0.620 |
Why?
|
Child, Preschool | 8 | 2023 | 1418 | 0.620 |
Why?
|
Cognition | 2 | 2024 | 398 | 0.570 |
Why?
|
Adult | 16 | 2023 | 11712 | 0.570 |
Why?
|
Cohort Studies | 7 | 2023 | 1492 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 643 | 0.540 |
Why?
|
Stress, Physiological | 1 | 2016 | 150 | 0.510 |
Why?
|
Confidentiality | 1 | 2015 | 26 | 0.500 |
Why?
|
Overweight | 1 | 2017 | 247 | 0.500 |
Why?
|
Research Support as Topic | 1 | 2015 | 80 | 0.490 |
Why?
|
Longitudinal Studies | 4 | 2024 | 885 | 0.470 |
Why?
|
Brain | 2 | 2023 | 1346 | 0.420 |
Why?
|
Infant | 5 | 2023 | 1046 | 0.400 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 47 | 0.390 |
Why?
|
Body Mass Index | 6 | 2023 | 854 | 0.380 |
Why?
|
Maternal Exposure | 2 | 2022 | 33 | 0.360 |
Why?
|
Breast Feeding | 2 | 2022 | 113 | 0.360 |
Why?
|
Pregnancy Outcome | 4 | 2020 | 87 | 0.340 |
Why?
|
Infant, Newborn | 5 | 2023 | 894 | 0.330 |
Why?
|
South Africa | 2 | 2019 | 35 | 0.330 |
Why?
|
Male | 11 | 2024 | 20025 | 0.320 |
Why?
|
Case-Control Studies | 3 | 2023 | 1130 | 0.300 |
Why?
|
Anxiety | 1 | 2014 | 754 | 0.290 |
Why?
|
Bayes Theorem | 2 | 2023 | 94 | 0.270 |
Why?
|
United States | 4 | 2019 | 4223 | 0.270 |
Why?
|
Environmental Exposure | 2 | 2018 | 216 | 0.270 |
Why?
|
Hypertension | 2 | 2023 | 796 | 0.260 |
Why?
|
Obesity | 3 | 2022 | 1067 | 0.230 |
Why?
|
Blood Pressure | 3 | 2023 | 646 | 0.230 |
Why?
|
Thiamine | 1 | 2023 | 5 | 0.220 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 8 | 0.220 |
Why?
|
Epidemiology | 1 | 2022 | 6 | 0.220 |
Why?
|
Blood Glucose | 2 | 2022 | 353 | 0.220 |
Why?
|
Fluorocarbons | 1 | 2023 | 26 | 0.210 |
Why?
|
Leucine | 1 | 2022 | 29 | 0.210 |
Why?
|
Glucose | 1 | 2024 | 230 | 0.210 |
Why?
|
Semen | 1 | 2022 | 51 | 0.210 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2022 | 53 | 0.210 |
Why?
|
Memory, Short-Term | 1 | 2022 | 49 | 0.200 |
Why?
|
Folic Acid | 1 | 2022 | 46 | 0.200 |
Why?
|
Micronutrients | 1 | 2022 | 44 | 0.200 |
Why?
|
Reproductive Medicine | 1 | 2021 | 6 | 0.200 |
Why?
|
Metabolome | 1 | 2021 | 53 | 0.200 |
Why?
|
Milk, Human | 1 | 2021 | 33 | 0.200 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 38 | 0.190 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 24 | 0.190 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 76 | 0.190 |
Why?
|
Young Adult | 4 | 2023 | 4268 | 0.190 |
Why?
|
Premature Birth | 1 | 2022 | 75 | 0.190 |
Why?
|
Preconception Care | 1 | 2020 | 8 | 0.190 |
Why?
|
Maternal Behavior | 1 | 2020 | 22 | 0.190 |
Why?
|
Hyperglycemia | 1 | 2021 | 55 | 0.190 |
Why?
|
Parents | 1 | 2024 | 329 | 0.190 |
Why?
|
Environmental Pollutants | 1 | 2023 | 179 | 0.180 |
Why?
|
Body Composition | 1 | 2021 | 162 | 0.180 |
Why?
|
Prenatal Care | 1 | 2020 | 73 | 0.180 |
Why?
|
Nutritional Status | 1 | 2020 | 116 | 0.180 |
Why?
|
Population Surveillance | 1 | 2020 | 238 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 44 | 0.170 |
Why?
|
Phenotype | 1 | 2021 | 689 | 0.160 |
Why?
|
Models, Statistical | 1 | 2019 | 180 | 0.160 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2018 | 14 | 0.160 |
Why?
|
Thyrotropin | 1 | 2018 | 17 | 0.160 |
Why?
|
Phthalic Acids | 1 | 2018 | 13 | 0.160 |
Why?
|
Social Mobility | 1 | 2017 | 1 | 0.160 |
Why?
|
Commerce | 1 | 2019 | 87 | 0.160 |
Why?
|
Empirical Research | 1 | 2017 | 5 | 0.150 |
Why?
|
World Health Organization | 1 | 2017 | 31 | 0.150 |
Why?
|
Uncertainty | 1 | 2017 | 26 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 23 | 0.150 |
Why?
|
Policy Making | 1 | 2017 | 31 | 0.150 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 97 | 0.150 |
Why?
|
Registries | 1 | 2019 | 335 | 0.150 |
Why?
|
Genetic Variation | 1 | 2020 | 387 | 0.150 |
Why?
|
Testosterone | 1 | 2018 | 193 | 0.150 |
Why?
|
Air Pollution | 1 | 2017 | 60 | 0.140 |
Why?
|
Spermatozoa | 1 | 2018 | 200 | 0.140 |
Why?
|
Genetic Association Studies | 1 | 2016 | 114 | 0.140 |
Why?
|
Health Policy | 1 | 2017 | 165 | 0.140 |
Why?
|
Genetic Markers | 1 | 2016 | 142 | 0.140 |
Why?
|
Social Environment | 1 | 2017 | 207 | 0.140 |
Why?
|
Diet | 1 | 2022 | 801 | 0.130 |
Why?
|
Antibodies, Viral | 1 | 2017 | 262 | 0.130 |
Why?
|
Government | 1 | 2015 | 6 | 0.130 |
Why?
|
Poverty | 1 | 2018 | 348 | 0.130 |
Why?
|
Adolescent | 3 | 2022 | 5363 | 0.120 |
Why?
|
Neurosciences | 1 | 2015 | 28 | 0.120 |
Why?
|
Washington | 1 | 2014 | 31 | 0.120 |
Why?
|
Calcifediol | 1 | 2014 | 15 | 0.120 |
Why?
|
Pregnancy Trimester, Second | 1 | 2014 | 16 | 0.120 |
Why?
|
Leisure Activities | 1 | 2014 | 33 | 0.120 |
Why?
|
Regression Analysis | 1 | 2015 | 455 | 0.120 |
Why?
|
Family | 1 | 2015 | 173 | 0.120 |
Why?
|
Research Personnel | 1 | 2015 | 155 | 0.110 |
Why?
|
Research | 1 | 2015 | 163 | 0.110 |
Why?
|
Age Factors | 1 | 2016 | 1033 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 253 | 0.110 |
Why?
|
Smoking | 1 | 2019 | 940 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 142 | 0.110 |
Why?
|
Triglycerides | 2 | 2023 | 138 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 182 | 0.100 |
Why?
|
Motor Activity | 1 | 2014 | 418 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2017 | 642 | 0.100 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 2721 | 0.100 |
Why?
|
Depression | 1 | 2014 | 712 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 974 | 0.070 |
Why?
|
Embryo Transfer | 1 | 2022 | 33 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2022 | 50 | 0.050 |
Why?
|
Abdominal Fat | 1 | 2021 | 21 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 68 | 0.050 |
Why?
|
Fasting | 1 | 2021 | 54 | 0.050 |
Why?
|
Sodium | 1 | 2021 | 103 | 0.050 |
Why?
|
Potassium | 1 | 2021 | 112 | 0.050 |
Why?
|
Surrogate Mothers | 1 | 2020 | 1 | 0.050 |
Why?
|
Pregnancy, Multiple | 1 | 2020 | 6 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2021 | 90 | 0.050 |
Why?
|
Siblings | 1 | 2020 | 18 | 0.050 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 23 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 39 | 0.050 |
Why?
|
Infertility | 1 | 2020 | 18 | 0.050 |
Why?
|
Fetal Development | 1 | 2020 | 29 | 0.050 |
Why?
|
Lipids | 1 | 2022 | 235 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 268 | 0.050 |
Why?
|
Water | 1 | 2022 | 296 | 0.040 |
Why?
|
Affect | 1 | 2020 | 152 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 282 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 739 | 0.040 |
Why?
|
Liver | 1 | 2021 | 479 | 0.040 |
Why?
|
Quebec | 1 | 2018 | 3 | 0.040 |
Why?
|
Semen Analysis | 1 | 2018 | 4 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 481 | 0.040 |
Why?
|
Israel | 1 | 2017 | 19 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2017 | 68 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2017 | 79 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2017 | 40 | 0.040 |
Why?
|
Demography | 1 | 2017 | 175 | 0.040 |
Why?
|
Family Characteristics | 1 | 2017 | 108 | 0.040 |
Why?
|
Linear Models | 1 | 2017 | 275 | 0.040 |
Why?
|
Prevalence | 1 | 2021 | 1455 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2017 | 237 | 0.040 |
Why?
|
California | 1 | 2017 | 476 | 0.030 |
Why?
|
Chronic Disease | 1 | 2017 | 484 | 0.030 |
Why?
|
Middle Aged | 1 | 2020 | 10129 | 0.020 |
Why?
|
Animals | 1 | 2021 | 15081 | 0.020 |
Why?
|